Taye Zeru
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Taye Zeru has a total of 165 co-authors. Here are the top co-authors by number of shared publications:
- Scott D. Nash
The Carter Center, Atlanta, Georgia, USA
15 shared publications - Zerihun Tadesse
The Carter Center Ethiopia, Addis Ababa, Ethiopia
9 shared publications - Ambahun Chernet
The Carter Center Ethiopia, Addis Ababa, Ethiopia
8 shared publications - Jeremy David Keenan
Francis I Proctor Foundation, University of California San Francisco, San Francisco, USA
8 shared publications - Solomon Aragie
The Carter Center Ethiopia Addis Ababa Ethiopia
8 shared publications - Elizabeth Kelly Callahan
The Carter Center, Atlanta, Georgia, USA
7 shared publications
Latest Publications
- 18 January 2026
- Published by Wiley in Tropical Medicine & International Health
- Vol. 31 (4) , 457-464
The Effect of a Water, Sanitation, and Hygiene Intervention on Clinical Trachoma: A Cluster‐Randomised Trial
Objectives: Few randomised trials have been done to assess the impact of hygiene interventions on trachoma even though hygiene improvements feature prominently in the strategy for global elimination of trachoma. This study's aim was to determine if implementing an integrated water, sanitation, and hygiene (WASH) intervention in a hyperendemic region of Ethiopia would reduce clinical signs of trachoma. Methods: In a parallel‐group cluster‐randomised trial, 40 Ethiopian communities were randomised in a 1:1 ratio to a WASH intervention or to delayed intervention (i.e., control) ( ClinicalTrials.gov NCT02754583). No antibiotic mass drug administration was undertaken. Annual monitoring visits included photography of the superior tarsal conjunctiva. Clinical trachoma—a pre‐specified secondary outcome—was assessed from photographs presented in a random order to masked photo‐graders. Results: At baseline, conjunctival photographs were taken on 1131 children aged 0–9 years in the WASH arm and 1229 children in the control arm. The mean number of follicles at baseline was 3.8 (95% CI: 3.1, 4.6) in the WASH arm and 3.7 (95% CI: 2.9, 4.4) in the control arm, which increased to a mean of 5.9 (95% CI: 5.1–6.6) in the WASH arm and 5.4 (95% CI: 4.6–6.1) in the control arm after 3 years (0.5 higher in the WASH arm, 95% CI: −0.6 to 1.5, p = 0.66). The mean papillary score increased from 3.3 (95% CI: 3.1–3.5) to 3.7 (95% CI: 3.5–3.9) in the WASH arm and from 3.2 (95% CI: 3.0–3.4) to 3.5 (95% CI: 3.3–3.7) in the control arm (month 36 values 0.2 greater in the WASH arm, 95% CI: −0.1 to 0.4; p = 0.49). No adverse events were reported in either treatment arm. Conclusions: An integrated WASH intervention delivered in the absence of mass antibiotic distributions did not reduce clinical trachoma outcomes in an area with hyperendemic trachoma.
- 18 January 2026
- Published by Wiley in Tropical Medicine & International Health
- Vol. 31 (4) , 457-464
The Effect of a Water, Sanitation, and Hygiene Intervention on Clinical Trachoma: A Cluster‐Randomised Trial
Objectives: Few randomised trials have been done to assess the impact of hygiene interventions on trachoma even though hygiene improvements feature prominently in the strategy for global elimination of trachoma. This study's aim was to determine if implementing an integrated water, sanitation, and hygiene (WASH) intervention in a hyperendemic region of Ethiopia would reduce clinical signs of trachoma. Methods: In a parallel‐group cluster‐randomised trial, 40 Ethiopian communities were randomised in a 1:1 ratio to a WASH intervention or to delayed intervention (i.e., control) ( ClinicalTrials.gov NCT02754583). No antibiotic mass drug administration was undertaken. Annual monitoring visits included photography of the superior tarsal conjunctiva. Clinical trachoma—a pre‐specified secondary outcome—was assessed from photographs presented in a random order to masked photo‐graders. Results: At baseline, conjunctival photographs were taken on 1131 children aged 0–9 years in the WASH arm and 1229 children in the control arm. The mean number of follicles at baseline was 3.8 (95% CI: 3.1, 4.6) in the WASH arm and 3.7 (95% CI: 2.9, 4.4) in the control arm, which increased to a mean of 5.9 (95% CI: 5.1–6.6) in the WASH arm and 5.4 (95% CI: 4.6–6.1) in the control arm after 3 years (0.5 higher in the WASH arm, 95% CI: −0.6 to 1.5, p = 0.66). The mean papillary score increased from 3.3 (95% CI: 3.1–3.5) to 3.7 (95% CI: 3.5–3.9) in the WASH arm and from 3.2 (95% CI: 3.0–3.4) to 3.5 (95% CI: 3.3–3.7) in the control arm (month 36 values 0.2 greater in the WASH arm, 95% CI: −0.1 to 0.4; p = 0.49). No adverse events were reported in either treatment arm. Conclusions: An integrated WASH intervention delivered in the absence of mass antibiotic distributions did not reduce clinical trachoma outcomes in an area with hyperendemic trachoma.
- 27 November 2025
- Published by Elsevier in International Journal of Hygiene and Environmental Health
- Vol. 271, 114718
Effect of water, sanitation, and hygiene on childhood growth in Ethiopia: a cluster-randomized trial
- 27 November 2025
- Published by Elsevier in International Journal of Hygiene and Environmental Health
- Vol. 271, 114718
Effect of water, sanitation, and hygiene on childhood growth in Ethiopia: a cluster-randomized trial
- Open Access
COVID-19 vaccine uptake and associated factors among health professionals: a facility-based, cross-sectional study in the Amhara region, Ethiopia
Objectives To determine uptake of the COVID-19 vaccine and identify the associated factors among health professionals in major cities of the Amhara region in Ethiopia. Design Institution-based, cross-sectional study. Setting The study was conducted from July to September 2022 across 40 health centres and 13 hospitals, representing 10 major cities within the Amhara region. Participants 1251 participants, all of whom were vaccine-eligible health professionals, were selected using a systematic random sampling procedure. Outcome measures The level of vaccine uptake in the study was determined by the proportion of health professionals who had received at least one dose of a COVID-19 vaccine. Results 1251 health professionals participated, with 848 (67.8%) reporting that they had received at least one dose of a COVID-19 vaccine. Key findings from the multivariable logistic regression analysis revealed that health professionals aged 46 years and older were four times more likely to be vaccinated (95% CI, 1.656 to 9.510), married participants were 1.4 times more likely to take the vaccine (95% CI, 1.010 to 1.933) and those with good knowledge of COVID-19 vaccines were 1.75 times more likely to get vaccinated (95% CI, 1.307 to 2.331). Additionally, participants with a positive attitude towards vaccination were 3.65 times more likely to have received a vaccine (95% CI, 2.753 to 4.732). Conclusions The study reveals a commendable level of COVID-19 vaccine uptake among health professionals, emphasising their critical role in public health initiatives. However, the observed disparities in vaccination rates indicate the need for targeted interventions to improve vaccine coverage, particularly among younger professionals and those with limited knowledge of the vaccine. Addressing these gaps requires the implementation of tailored educational programmes that enhance understanding of COVID-19 vaccines. Furthermore, fostering positive attitudes through targeted campaigns, workplace-based initiatives and peer influence, particularly among younger and unmarried professionals, will be crucial. Encouraging vaccinated professionals to share their experiences and establishing regular follow-ups will also be essential strategies to improve vaccine acceptance and coverage in the region.
Open AccessCOVID-19 vaccine uptake and associated factors among health professionals: a facility-based, cross-sectional study in the Amhara region, Ethiopia
Objectives To determine uptake of the COVID-19 vaccine and identify the associated factors among health professionals in major cities of the Amhara region in Ethiopia. Design Institution-based, cross-sectional study. Setting The study was conducted from July to September 2022 across 40 health centres and 13 hospitals, representing 10 major cities within the Amhara region. Participants 1251 participants, all of whom were vaccine-eligible health professionals, were selected using a systematic random sampling procedure. Outcome measures The level of vaccine uptake in the study was determined by the proportion of health professionals who had received at least one dose of a COVID-19 vaccine. Results 1251 health professionals participated, with 848 (67.8%) reporting that they had received at least one dose of a COVID-19 vaccine. Key findings from the multivariable logistic regression analysis revealed that health professionals aged 46 years and older were four times more likely to be vaccinated (95% CI, 1.656 to 9.510), married participants were 1.4 times more likely to take the vaccine (95% CI, 1.010 to 1.933) and those with good knowledge of COVID-19 vaccines were 1.75 times more likely to get vaccinated (95% CI, 1.307 to 2.331). Additionally, participants with a positive attitude towards vaccination were 3.65 times more likely to have received a vaccine (95% CI, 2.753 to 4.732). Conclusions The study reveals a commendable level of COVID-19 vaccine uptake among health professionals, emphasising their critical role in public health initiatives. However, the observed disparities in vaccination rates indicate the need for targeted interventions to improve vaccine coverage, particularly among younger professionals and those with limited knowledge of the vaccine. Addressing these gaps requires the implementation of tailored educational programmes that enhance understanding of COVID-19 vaccines. Furthermore, fostering positive attitudes through targeted campaigns, workplace-based initiatives and peer influence, particularly among younger and unmarried professionals, will be crucial. Encouraging vaccinated professionals to share their experiences and establishing regular follow-ups will also be essential strategies to improve vaccine acceptance and coverage in the region.
- Open Access
Annual versus biannual azithromycin mass drug administration for the elimination of infectious trachoma in Africa: protocol for a systematic review and meta-analysis using data from individual communities
Introduction: Trachoma is an infectious eye disease caused byChlamydia trachomatisand the leading infectious cause of blindness worldwide. WHO recommends community-wide oral azithromycin treatment as part of its trachoma elimination strategy. WHO initially recommended mass drug administration (MDA) with azithromycin once per year for several years, followed by reassessment. However, some districts have failed to eliminate trachoma even after a decade of annual MDA with azithromycin. As a result, WHO has recently advocated for more frequent antibiotics in districts with persistent trachoma. Although no specific frequency of antibiotic distributions has been recommended, several randomised trials have compared annual with biannual mass azithromycin distributions. This review aims to synthesise the available data to assess the effectiveness of biannual azithromycin MDA relative to annual MDA.Methods and analysis: PubMed, Embase, Web of Science, Scopus and Google Scholar will be searched for studies comparing annual and biannual mass azithromycin distributions for trachoma. Community-level data will be extracted using a standardised data extraction form. Authors will be asked to contribute community-level data not available in the manuscript. The main outcome will beC. trachomatisinfection among 1–9-year-old children, expressed as a community-level prevalence. A secondary outcome will be the presence of trachomatous inflammation-follicular. The analysis will follow principles of a one-stage individual participant data meta-analysis using complete case mixed-effects regression models with a random effect for study to model community-level prevalence data. Statistical heterogeneity will be assessed with theI2statistic.Ethics and dissemination: The research will use community-aggregated data and is thus exempt from ethical approval. The results will be submitted for publication in a peer-reviewed journal.PROSPERO registration number: CRD42024526120.
Open AccessAnnual versus biannual azithromycin mass drug administration for the elimination of infectious trachoma in Africa: protocol for a systematic review and meta-analysis using data from individual communities
Introduction: Trachoma is an infectious eye disease caused byChlamydia trachomatisand the leading infectious cause of blindness worldwide. WHO recommends community-wide oral azithromycin treatment as part of its trachoma elimination strategy. WHO initially recommended mass drug administration (MDA) with azithromycin once per year for several years, followed by reassessment. However, some districts have failed to eliminate trachoma even after a decade of annual MDA with azithromycin. As a result, WHO has recently advocated for more frequent antibiotics in districts with persistent trachoma. Although no specific frequency of antibiotic distributions has been recommended, several randomised trials have compared annual with biannual mass azithromycin distributions. This review aims to synthesise the available data to assess the effectiveness of biannual azithromycin MDA relative to annual MDA.Methods and analysis: PubMed, Embase, Web of Science, Scopus and Google Scholar will be searched for studies comparing annual and biannual mass azithromycin distributions for trachoma. Community-level data will be extracted using a standardised data extraction form. Authors will be asked to contribute community-level data not available in the manuscript. The main outcome will beC. trachomatisinfection among 1–9-year-old children, expressed as a community-level prevalence. A secondary outcome will be the presence of trachomatous inflammation-follicular. The analysis will follow principles of a one-stage individual participant data meta-analysis using complete case mixed-effects regression models with a random effect for study to model community-level prevalence data. Statistical heterogeneity will be assessed with theI2statistic.Ethics and dissemination: The research will use community-aggregated data and is thus exempt from ethical approval. The results will be submitted for publication in a peer-reviewed journal.PROSPERO registration number: CRD42024526120.
- Open Access
- 5 December 2024
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 9 (12) , 298
Correlates of Trachoma Recrudescence: Results from 51 District-Level Trachoma Surveillance Surveys in Amhara, Ethiopia
Trachoma recrudescence is a serious concern for trachoma control programs. Programs define recrudescence as the return of trachomatous inflammation-follicular (TF) prevalence above elimination threshold (≥5%) on district-level trachoma surveillance surveys (TSSs). This study aimed to determine potential correlates of trachoma recrudescence within a historically highly endemic region. Between 2015 and 2021, population-based TSSs were conducted in 51 districts of Amhara, Ethiopia. District estimates were calculated accounting for multistage design; logistic regression was used to estimate the association of key correlates with recrudescence at the district level. Among the 51 districts, 17 (33%) were recrudescent. Correlates of recrudescence included indicators of historic trachoma burden, such as higher trachomatous inflammation-intense (TI) prevalence (odds ratio [OR]: 2.6, CI: 1.4–5.3) and higher Chlamydia trachomatis (Ct) infection prevalence (OR: 2.9, CI: 1.1–9.9) at the first recorded impact survey. The increased prevalence of children with clean faces (OR: 0.4, CI: 0.21–1.0) and the increased prevalence of travel time to a water source ≤ 30 min (OR: 0.5, CI: 0.2–1.1) at the TSS were associated with a protective effect from recrudescence. Data on historical trachoma burden as well as current water and sanitation conditions may help programs predict where recrudescence is more likely to occur and thus help programs sustain elimination as a public health problem.
- 5 December 2024
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 9 (12) , 298
Open AccessCorrelates of Trachoma Recrudescence: Results from 51 District-Level Trachoma Surveillance Surveys in Amhara, Ethiopia
Trachoma recrudescence is a serious concern for trachoma control programs. Programs define recrudescence as the return of trachomatous inflammation-follicular (TF) prevalence above elimination threshold (≥5%) on district-level trachoma surveillance surveys (TSSs). This study aimed to determine potential correlates of trachoma recrudescence within a historically highly endemic region. Between 2015 and 2021, population-based TSSs were conducted in 51 districts of Amhara, Ethiopia. District estimates were calculated accounting for multistage design; logistic regression was used to estimate the association of key correlates with recrudescence at the district level. Among the 51 districts, 17 (33%) were recrudescent. Correlates of recrudescence included indicators of historic trachoma burden, such as higher trachomatous inflammation-intense (TI) prevalence (odds ratio [OR]: 2.6, CI: 1.4–5.3) and higher Chlamydia trachomatis (Ct) infection prevalence (OR: 2.9, CI: 1.1–9.9) at the first recorded impact survey. The increased prevalence of children with clean faces (OR: 0.4, CI: 0.21–1.0) and the increased prevalence of travel time to a water source ≤ 30 min (OR: 0.5, CI: 0.2–1.1) at the TSS were associated with a protective effect from recrudescence. Data on historical trachoma burden as well as current water and sanitation conditions may help programs predict where recrudescence is more likely to occur and thus help programs sustain elimination as a public health problem.
- 4 December 2024
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 111 (6) , 1256-1258
Correlation of Clinical Severity of Trachomatous Inflammation and Chlamydia trachomatis Bacterial Load
: The purpose of this study was to investigate the correlation between bacterial load of Chlamydia trachomatis as measured from quantitative polymerase chain reaction (qPCR) and the relative clinical severity of trachomatous inflammation. Individuals with trachoma from rural communities in Ethiopia had photographs taken as well as swabs obtained of the upper tarsal conjunctivas. Conjunctival swabs were processed with PCR assay, which provided quantitative results of ocular chlamydial load. A series of 125 conjunctival photographs were ranked from least to most severe according to clinical severity for follicular and papillary conjunctivitis. Higher intensity rankings of trachomatous inflammation were associated with higher chlamydial load for both follicular inflammation (Spearman’s ρ = 0.43; P P <0.001). Rankings of trachomatous inflammation may be a clinically meaningful indicator of trachoma.
- 4 December 2024
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 111 (6) , 1256-1258
Correlation of Clinical Severity of Trachomatous Inflammation and Chlamydia trachomatis Bacterial Load
: The purpose of this study was to investigate the correlation between bacterial load of Chlamydia trachomatis as measured from quantitative polymerase chain reaction (qPCR) and the relative clinical severity of trachomatous inflammation. Individuals with trachoma from rural communities in Ethiopia had photographs taken as well as swabs obtained of the upper tarsal conjunctivas. Conjunctival swabs were processed with PCR assay, which provided quantitative results of ocular chlamydial load. A series of 125 conjunctival photographs were ranked from least to most severe according to clinical severity for follicular and papillary conjunctivitis. Higher intensity rankings of trachomatous inflammation were associated with higher chlamydial load for both follicular inflammation (Spearman’s ρ = 0.43; P P <0.001). Rankings of trachomatous inflammation may be a clinically meaningful indicator of trachoma.
- Open Access
- 3 September 2024
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 111 (3_Suppl) , 105-113
The Epidemiology of Ocular Chlamydia trachomatis Infection within Districts Persistently Endemic for Trachoma in Amhara, Ethiopia
: Persistent trachoma is a growing concern to trachoma control programs globally and programs serving Ethiopia specifically. Persistent trachoma is defined as a district with two or more trachoma impact surveys (TISs) at which the prevalence of trachomatous inflammation-follicular (TF) among children ages 1–9 years is ≥5%, the elimination threshold. Because the global target for trachoma elimination as a public health problem is 2030, research is needed to better characterize persistent trachoma. This study described the epidemiology of ocular Chlamydia trachomatis infection, the causative bacteria of trachoma, in seven contiguous districts experiencing persistent trachoma. In 2019, multistage cluster random sampling TISs were conducted in the seven districts after 10 years of interventions. All individuals ages ≥1 year were examined for trachoma clinical signs by certified graders, and conjunctival swabs were collected from children ages 1–5 years to test for C. trachomatis infection. The district TF prevalence ranged from 11.8% (95% CI:7.6–16.0%) to 36.1% (95% CI:27.4–44.3%). The range of district-level C. trachomatis infection prevalence was between 2.7% and 34.4%. Statistically significant spatial clustering of high-infection communities was observed in the study districts, and children with infection were more likely than those without to be found in households with clinical signs of trachoma and those without latrines. These seven districts appear to constitute a persistent hotspot in Amhara, where an additional 3–5 years or more of interventions will be required. The global program will need to strengthen and enhance intervention strategies within persistent districts if elimination by 2030 is to be achieved.
- 3 September 2024
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 111 (3_Suppl) , 105-113
Open AccessThe Epidemiology of Ocular Chlamydia trachomatis Infection within Districts Persistently Endemic for Trachoma in Amhara, Ethiopia
: Persistent trachoma is a growing concern to trachoma control programs globally and programs serving Ethiopia specifically. Persistent trachoma is defined as a district with two or more trachoma impact surveys (TISs) at which the prevalence of trachomatous inflammation-follicular (TF) among children ages 1–9 years is ≥5%, the elimination threshold. Because the global target for trachoma elimination as a public health problem is 2030, research is needed to better characterize persistent trachoma. This study described the epidemiology of ocular Chlamydia trachomatis infection, the causative bacteria of trachoma, in seven contiguous districts experiencing persistent trachoma. In 2019, multistage cluster random sampling TISs were conducted in the seven districts after 10 years of interventions. All individuals ages ≥1 year were examined for trachoma clinical signs by certified graders, and conjunctival swabs were collected from children ages 1–5 years to test for C. trachomatis infection. The district TF prevalence ranged from 11.8% (95% CI:7.6–16.0%) to 36.1% (95% CI:27.4–44.3%). The range of district-level C. trachomatis infection prevalence was between 2.7% and 34.4%. Statistically significant spatial clustering of high-infection communities was observed in the study districts, and children with infection were more likely than those without to be found in households with clinical signs of trachoma and those without latrines. These seven districts appear to constitute a persistent hotspot in Amhara, where an additional 3–5 years or more of interventions will be required. The global program will need to strengthen and enhance intervention strategies within persistent districts if elimination by 2030 is to be achieved.
- Open Access
- 20 August 2024
- Published by Qeios Ltd
Review of: "COVID-19 Vaccine Effectiveness Against Long-COVID-19 Condition in Pakistan"
The work presented is commendable and has the potential for publication. However, there is a noticeable misalignment between the stated objective and the title of the manuscript. The primary aim of the study appears to be an assessment of Long COVID-...
- 20 August 2024
- Published by Qeios Ltd
Open AccessReview of: "COVID-19 Vaccine Effectiveness Against Long-COVID-19 Condition in Pakistan"
The work presented is commendable and has the potential for publication. However, there is a noticeable misalignment between the stated objective and the title of the manuscript. The primary aim of the study appears to be an assessment of Long COVID-...
- Open Access
- 20 August 2024
- Published by Qeios Ltd
Review of: "COVID-19 Vaccine Effectiveness Against Long-COVID-19 Condition in Pakistan"
The research work you've conducted is of high quality and has the potential to be published. However, there is a significant issue with the alignment between the study's objective and its title, which needs to be addressed for clarity and precision....
- 20 August 2024
- Published by Qeios Ltd
Open AccessReview of: "COVID-19 Vaccine Effectiveness Against Long-COVID-19 Condition in Pakistan"
The research work you've conducted is of high quality and has the potential to be published. However, there is a significant issue with the alignment between the study's objective and its title, which needs to be addressed for clarity and precision....
- 22 December 2023
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 230 (2) , 293-297
Seroreversion to Chlamydia trachomatis Pgp3 Antigen Among Children in a Hyperendemic Region of Amhara, Ethiopia
Monitoring trachoma transmission with antibody data requires characterization of decay in IgG to Chlamydia trachomatis antigens. In a three-year longitudinal cohort in a high transmission setting, we estimated a median IgG half-life of 3 years and a seroreversion rate of 2.5 (95% CI: 1.6, 3.5) per 100 person-years.
- 22 December 2023
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 230 (2) , 293-297
Seroreversion to Chlamydia trachomatis Pgp3 Antigen Among Children in a Hyperendemic Region of Amhara, Ethiopia
Monitoring trachoma transmission with antibody data requires characterization of decay in IgG to Chlamydia trachomatis antigens. In a three-year longitudinal cohort in a high transmission setting, we estimated a median IgG half-life of 3 years and a seroreversion rate of 2.5 (95% CI: 1.6, 3.5) per 100 person-years.